PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

The stock's fall snapped a two-day winning streak.

Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

PTC Industries inks aerospace MoU with Odisha government, sparking a nearly 5% rally in the company’s stock price.

One of the top advanced manufacturing and material technology companies, PTC Industries, has inked a Memorandum of ...

Check the time stamp on this data. Updated AI-Generated Signals for Ptc Inc. (PTC) available here: PTC. Type a few symbols ...

The U.S. Department of the Treasury and IRS on Jan. 10, 2025, released initial guidance regarding the production tax credit (PTC) for clean ...

PTC automatically controls train speeds when needed, reducing the risk of train collisions and preventing human error, while ...

Actor-politician says, 'Bodies of those who died in the stampede have been thrown into the river, polluting the water' ...